Dapagliflozin to Reduce the Decline in Renal Function in Patients Newly Diagnosed With Lupus Nephritis

Clinical trial NCT07678203 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07678203
Sponsor: Hospital Civil Juan I. Menchaca
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Lupus Nephritis (LN)Chronic Kidney Disease SGLT 2 Inhibitors Systemic Lupus Erythematosus

Start date: 2026-05-28
Primary completion: 2027-01-28
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.